Advertisement

Topics

Phathom gets $140mm through crossover round and debt facility

15:40 EDT 16 May 2019 | Elsevier Business Intelligence

Phathom Pharmaceuticals, a new company launched by Takeda Pharmaceuticals and Frazier Healthcare Partners, raised $90mm in a ...

Original Article: Phathom gets $140mm through crossover round and debt facility

NEXT ARTICLE

More From BioPortfolio on "Phathom gets $140mm through crossover round and debt facility"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...